Lung Cancer News and Research

RSS
Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).
Understanding How Cell-to-Cell Communication Networks Drive Pancreatic Cancer Development

Understanding How Cell-to-Cell Communication Networks Drive Pancreatic Cancer Development

Prime Editing System Could Accelerate the Study of Cancer-Linked Mutations

Prime Editing System Could Accelerate the Study of Cancer-Linked Mutations

Researchers Create a Computational Tool to Gain New Insights From Multi-Omics Data

Researchers Create a Computational Tool to Gain New Insights From Multi-Omics Data

Identifying Lung Cancer Patients Who May Not Respond Well to Immunotherapy by MYC Gene Activation

Identifying Lung Cancer Patients Who May Not Respond Well to Immunotherapy by MYC Gene Activation

A New, Cost-Effective Therapy to Treat a Wide Range of Cancers

A New, Cost-Effective Therapy to Treat a Wide Range of Cancers

Novel Tridimensional Anticancer Agents Have the Ability to Overcome Drug Resistance in Cancer Cells

Novel Tridimensional Anticancer Agents Have the Ability to Overcome Drug Resistance in Cancer Cells

Insights into mechanisms impacting NSCLC disease progression

Insights into mechanisms impacting NSCLC disease progression

Additional therapeutic maneuver may be needed to stop some metastasized tumors                                               Cancer That...

Additional therapeutic maneuver may be needed to stop some metastasized tumors Cancer That...

3D cell culture system may be a valuable tool for assessing drug efficacy on tumor growth

3D cell culture system may be a valuable tool for assessing drug efficacy on tumor growth

Macrophages likely to be a potential target for ER+ breast cancer

Macrophages likely to be a potential target for ER+ breast cancer

Immune landscape in invasive ER+ breast cancers reveals a macrophage-driven microenvironment

Immune landscape in invasive ER+ breast cancers reveals a macrophage-driven microenvironment

Neoadjuvant dual immunotherapy and chemotherapy improve outcomes in patients with resectable NSCLC

Neoadjuvant dual immunotherapy and chemotherapy improve outcomes in patients with resectable NSCLC

Potential approach to improve solid tumor T cell therapy

Potential approach to improve solid tumor T cell therapy

Using PET and electron microscopy to generate 3D maps of mitochondrial networks in lung tumors

Using PET and electron microscopy to generate 3D maps of mitochondrial networks in lung tumors

New center offers electron microscope services to the scientific community

New center offers electron microscope services to the scientific community

Strata Oncology publishes study validating integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Strata Oncology publishes study validating integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Study sheds light on why lung tumors do not respond well to immunotherapy

Study sheds light on why lung tumors do not respond well to immunotherapy

A high-throughput drug discovery assay for the endoplasmic reticulum aminopeptidase 1

A high-throughput drug discovery assay for the endoplasmic reticulum aminopeptidase 1

Novel adoptive T cell receptor therapy shows promising results for patients with solid tumors

Novel adoptive T cell receptor therapy shows promising results for patients with solid tumors

Persistent tumor mutation load may help predict outcome of novel immunotherapies

Persistent tumor mutation load may help predict outcome of novel immunotherapies